Nli International Inc decreased its stake in Patterson Companies Inc (NASDAQ:PDCO) by 51.37% based on its latest 2016Q1 regulatory filing with the SEC.
Becton Dickinson has been the topic of 14 analyst reports since August 7, 2015 according to StockzIntelligence Inc. Below is a list of Becton Dickinson and Co (NYSE:BDX) latest ratings and price target changes.
Welcome and thank you for standing by. At this time all participants are in listen-only mode. Today's conference is being recorded.
Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas.
Becton, Dickinson and Company is a global medical technology firm engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical ...
James Dondero decreased its stake in Patterson Companies Inc (NASDAQ:PDCO) by 48.3% based on its latest 2016Q1 regulatory filing with the SEC.